GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncolys BioPharma Inc (TSE:4588) » Definitions » Price-to-Operating-Cash-Flow

Oncolys BioPharma (TSE:4588) Price-to-Operating-Cash-Flow : (As of Dec. 13, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Oncolys BioPharma Price-to-Operating-Cash-Flow?

As of today (2024-12-13), Oncolys BioPharma's share price is 円656.00. Oncolys BioPharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was 円0.00. Hence, Oncolys BioPharma's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Oncolys BioPharma's Price-to-Operating-Cash-Flow or its related term are showing as below:

TSE:4588's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 25.83
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Oncolys BioPharma's Cash Flow from Operations per share for the three months ended in Jun. 2024 was 円0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was 円0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 9.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -11.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 1.30% per year.

During the past 12 years, Oncolys BioPharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was 44.10% per year. The lowest was -79.60% per year. And the median was -3.40% per year.


Oncolys BioPharma Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Oncolys BioPharma's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncolys BioPharma Price-to-Operating-Cash-Flow Chart

Oncolys BioPharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Oncolys BioPharma Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Oncolys BioPharma's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Oncolys BioPharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncolys BioPharma's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncolys BioPharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Oncolys BioPharma's Price-to-Operating-Cash-Flow falls into.



Oncolys BioPharma Price-to-Operating-Cash-Flow Calculation

Oncolys BioPharma's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=656.00/0
=

Oncolys BioPharma's Share Price of today is 円656.00.
Oncolys BioPharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Oncolys BioPharma Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Oncolys BioPharma's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncolys BioPharma Business Description

Traded in Other Exchanges
N/A
Address
4-1-28 Toranomon, Toranomon Towers Office, Minato-ku, Tokyo, JPN, 105-0001
Oncolys BioPharma Inc develops pharmaceutical products. The company is engaged in research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents.

Oncolys BioPharma Headlines

No Headlines